−400KRW
−32.88 BKRW
354.89 BKRW
28.17 M
About SKBP
Sector
CEO
Dong-Hoon Lee
Headquarters
Seongnam-si
Website
Employees (FY)
273
Founded
1993
ISIN
KR7326030004
FIGI
BBG00GK8B7Y9
SK Biopharmaceuticals Co., Ltd. engages in the research and development of new drugs and antibiotics. It mainly develops new drugs for central nervous system disorders, and brain tumors. The company was founded in 1993 and is headquartered in Seongnam-si, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 326030 is 83300 KRW — it has decreased by 2.00% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange SKBP stocks are traded under the ticker 326030.
SKBP is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
326030 stock is 2.41% volatile and has beta coefficient of 1.06. Check out the list of the most volatile stocks — is SKBP there?
326030 earnings for the last quarter are −235.08 KRW per share, whereas the estimation was −333.22 KRW resulting in a 29.45% surprise. The estimated earnings for the next quarter are 47.63 KRW per share. See more details about SKBP earnings.
SKBP revenue for the last quarter amounts to 90.30 B KRW despite the estimated figure of 92.74 B KRW. In the next quarter revenue is expected to reach 107.23 B KRW.
Yes, you can track SKBP financials in yearly and quarterly reports right on TradingView.
326030 stock has risen by 2.21% compared to the previous week, the month change is a 13.77% fall, over the last year SKBP has showed a 19.86% increase.
326030 net income for the last quarter is 6.76 B KRW, while the quarter before that showed −13.93 B KRW of net income which accounts for 148.52% change. Track more SKBP financial stats to get the full picture.
Today SKBP has the market capitalization of 6.66 T, it has increased by 3.19% over the last week.
No, 326030 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 326030 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SKBP stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 25, 2024, the company has 273.00 employees. See our rating of the largest employees — is SKBP on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SKBP technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SKBP stock shows the sell signal. See more of SKBP technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on SKBP future price: according to them, 326030 price has a max estimate of 130000.00 KRW and a min estimate of 51000.00 KRW. Read a more detailed SKBP forecast: see what analysts think of SKBP and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SKBP EBITDA is −22.62 B KRW, and current EBITDA margin is −6.42%. See more stats in SKBP financial statements.